Loading company…
ID 434172977 · FY 2019–2023 · 5 years
1.2 კომპანიის ძირითად საქმიანობას წარმოადგენს: - საბითუმო და საცალო ვაჭრობა ფარმაცევტული საქონლით.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|
| Total Revenue | 3,728 | 4,622 | 7,695 | 12,522 | 10,961 | +30.9% |
| Total COGS | -1,575 | -2,057 | -3,440 | -5,550 | -4,135 | +27.3% |
| Gross Profit | 2,153 | 2,565 | 4,255 | 6,972 | 6,826 | +33.4% |
| Gross Margin | 57.7% | 55.5% | 55.3% | 55.7% | 62.3% | |
| Total Operating Expenses | -905 | -1,416 | -1,880 | -2,388 | -4,047 | +45.4% |
| EBITDA | 1,248 | 1,150 | 2,375 | 4,584 | 2,779 | +22.2% |
| EBITDA Margin | 33.5% | 24.9% | 30.9% | 36.6% | 25.4% | |
| Total D&A | -1 | -5 | -8 | -15 | -27 | +159.6% |
| EBIT / Operating Income | 1,247 | 1,145 | 2,367 | 4,569 | 2,752 | +21.9% |
| Total Interest Expense | -2 | -8 | -27 | -40 | -90 | +163.5% |
| Total Other Income | -24 | -120 | 667 | 821 | 145 | nmf |
| Profit Before Tax | 1,222 | 1,017 | 3,006 | 5,350 | 2,807 | +23.1% |
| Total Income Tax | -31 | -82 | -157 | -244 | -210 | +61.7% |
| Net Profit / (Loss) | 1,191 | 807 | 2,805 | 4,715 | 2,560 | +21.1% |
| Net Margin | 32.0% | 17.5% | 36.5% | 37.7% | 23.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).